QURE - Uniqure NV - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

QURE is currently covered by 12 analysts with an average price target of $36.59. This is a potential upside of $23.8 (186.08%) from yesterday's end of day stock price of $12.79.

Uniqure NV's activity chart (see below) currently has 83 price targets and 115 ratings on display. The stock rating distribution of QURE is 78.57% BUY and 21.43% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.31% with an average time for these price targets to be met of 223.81 days.

Highest price target for QURE is $70, Lowest price target is $20, average price target is $37.88.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 20-Apr-2025. First documented stock forecast 17-May-2015.

Currently out of the existing stock ratings of QURE, 33 are a BUY (78.57%), 9 are a HOLD (21.43%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$70

$57.21 (447.30%)

$70

21 days ago
(20-Apr-2025)

0/11 (0%)

$56.71 (426.71%)

Buy

$24

$11.21 (87.65%)

$24

3 months 21 days ago
(20-Jan-2025)

1/7 (14.29%)

$9.09 (60.97%)

34

Hold

$20

$7.21 (56.37%)

$6

4 months 23 days ago
(18-Dec-2024)

3/4 (75%)

$4.53 (29.28%)

132

Buy

$32

$19.21 (150.20%)

$37

4 months 26 days ago
(15-Dec-2024)

0/3 (0%)

$14.6 (83.91%)

Hold

$20

$7.21 (56.37%)

$9

5 months ago
(11-Dec-2024)

3/6 (50%)

$4.94 (32.80%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is QURE (Uniqure NV) average time for price targets to be met?

On average it took 223.81 days on average for the stock forecasts to be realized with a an average price target met ratio 38.31

Which analyst has the current highest performing score on QURE (Uniqure NV) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on QURE (Uniqure NV)?

Elemer Piros has 6 price targets and 6 ratings on QURE

Which analyst is the currently most bullish on QURE (Uniqure NV)?

Elemer Piros with highest potential upside - $79.82

Which analyst is the currently most reserved on QURE (Uniqure NV)?

Gbola Amusa with lowest potential downside - -$0

Uniqure NV in the News

uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress

~ AMT-130 granted Breakthrough Therapy designation by FDA ~ ~ Initial safety data from third cohort of Phase I/II study show AMT-130 continues to be generally well-tolerated, with no treatment-related serious adverse events ~ ~ Held Type B FDA meetings in the first and second quarters of 2025 to advance BLA preparations for AMT-130; regulatory...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?